Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
      • Applying for overseas supply of blood products
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
      • Applying for overseas supply of blood products
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Artificial Intelligence (AI) use in Recruitment

  • Home
  • Artificial Intelligence (AI) use in Recruitment

Purpose

The National Blood Authority’s (NBA) commitment to the safe and responsible use of artificial intelligence (AI) supports our vision to save and improve Australian lives and patient outcomes through a world-class blood supply. For more information, visit our AI transparency statement page.

This page explains how the NBA may use AI tools in recruitment processes and how candidates may use AI tools when applying for a role with the NBA. It is intended to support transparent, fair and merit-based recruitment practices and has been developed in accordance with reference to the Australian Public Service Commission’s Principles for candidate use of AI in recruitment(Opens in a new tab/window) and Principles for Agency use of AI in recruitment.(Opens in a new tab/window) 

How we use AI in recruitment

Candidate use of AI

The NBA is committed to recruitment processes that are fair and based on merit, including each candidate's skills, experience and suitability for the role. 

The NBA recognises that AI may assist candidates during a recruitment process. Candidates may choose to use AI tools to support aspects of their application, such as drafting or refining written responses or preparing for interviews. Where AI use is not permitted for a particular assessment activity, this will be stated in the job advertisement or candidate instructions. 

We expect all candidates to participate in recruitment processes with integrity and honesty, consistent with the  Australian Public Service (APS) Values(Opens in a new tab/window) and the APS Principles for candidate use of AI in recruitment.(Opens in a new tab/window) This includes being transparent about the use of AI during the recruitment process. 

When applying for a role with the NBA, candidates are expected to:

  • Follow all instructions in the Job Advertisement.
  • Act with honesty and ensure the information provided reflects your own skills, experiences and achievements. This includes using your own knowledge and judgement when responding to interview questions, written or skills assessments.
  • Be transparent. If you use AI tools to support or participate in the recruitment process, you may be asked to explain how AI was used. You remain responsible for ensuring that anything you submit is factually correct and a genuine representation of your own experience and work.
  • Use AI responsibly. Do not use AI to invent, exaggerate, or misrepresent your experience, qualifications, achievements or responses. Using AI in a way that misrepresents your capability may undermine the integrity of the recruitment process and is inconsistent with the APS merit-based recruitment principles.(Opens in a new tab/window) 

These expectations support a transparent, fair and merit-based recruitment process. 

Agency use of AI

The NBA is committed to being transparent about the use of AI tools in its recruitment processes. AI may be used in limited ways to support administrative efficiency, such as drafting job advertisements, role documentation or other recruitment materials. The NBA does not use AI to assess, screen, rank, shortlist or make decisions about candidates. All recruitment decisions, including role requirements, shortlisting and progression decisions, are made by human selection panels and delegates in accordance with APS merit principles.

External recruitment providers engaged by the NBA are also expected to comply with these requirements and are not permitted to use AI to assess, screen, rank, shortlist or make decisions about candidates on the NBA’s behalf. 

Using AI the right way 

Candidates should avoid entering personal, sensitive, confidential or security-classified information into public AI tools. If you choose to use AI, use it as a support only and not as a substitute for your own judgement, capability and authentic input.

AI-generated content may be inaccurate, incomplete or misleading. Candidates are responsible for reviewing and verifying any AI-assisted content before submitting it. You should ensure your application reflects your own understanding and judgement of the role, particularly in written responses, interviews and assessment activities where the NBA is seeking to assess your individual suitability.

 

 

 

 

 

 

 

 

Last updated: 02 Jun 2026

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback